Dynavax Technologies | DVAX - Trade Debtors

Stock Price
15.50
Daily Change
0.01 0.06%
Monthly
0.58%
Yearly
17.87%
Q1 Forecast
15.01

Dynavax Technologies reported $73.34M in Trade Debtors for its fiscal quarter ending in June of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Adma Biologics USD 137.67M 27.94M Sep/2025
Amgen USD 8.49B 211M Sep/2025
AstraZeneca USD 17.56B 1.32B Sep/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Dynavax Technologies USD 73.34M 16.79M Jun/2025
Gilead Sciences USD 5.1B 314M Sep/2025
Glaxosmithkline GBP 11.16B 3.46B Sep/2025
Merck USD 12.12B 596M Sep/2025
Neurocrine Biosciences USD 728M 132.3M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025